Bholasingh R, de Winter R J, Fischer J C, Koster R W, Peters R J, Sanders G T
Department of Cardiology, Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands.
Heart. 2001 Feb;85(2):143-8. doi: 10.1136/heart.85.2.143.
To determine whether a new protocol, using a rapid and sensitive CK-MB(mass) assay and serial sampling, can rule out myocardial infarction in patients with chest pain and decrease their length of stay in the cardiac emergency room without increasing risk.
The combined incidence of cardiac death and acute myocardial infarction at 30 days, six months, and 24 months of follow up were compared between patients discharged home from the cardiac emergency room after ruling out myocardial infarction with a CK-MB(activity) assay in 1994 and those discharged home after a rapid CK-MB(mass) assay in 1996.
Cardiac emergency room of a large university hospital.
In 1994 and 1996, 230 and 423 chest pain patients, respectively, were discharged home from the cardiac emergency room with a normal CK-MB and an uneventful observation period.
The median length of stay in the cardiac emergency room was significantly reduced, from 16.0 hours in 1994 to 9.0 hours in 1996 (p < 0.0001). Mean event rates in patients from the 1994 and 1996 cohorts, respectively, were 0.9% (95% confidence interval (CI) -0.3% to 2.1%) v 0.7% (95% CI -0.1% to 1. 5%) at 30 days, 3.0% (95% CI 0.8% to 5.2%) v 2.8% (95% CI 1.2% to 4. 4%) at six months, and 7.0% (95% CI 3.7% to 10.3%) v 5.7% (95% CI 3. 5% to 7.9%) at 24 months. Kaplan-Meier survival analysis showed no difference in mean event-free survival at 30 days, six months, and 24 months of follow up.
Using a rule-out myocardial infarction protocol with a rapid and sensitive CK-MB(mass) assay and serial sampling, the length of stay of patients with chest pain in the cardiac emergency room can be reduced without compromising safety.
确定一种新方案,即采用快速灵敏的肌酸激酶同工酶MB(质量法)检测及系列采样,能否排除胸痛患者的心肌梗死,并缩短其在心脏急诊室的留观时间,同时不增加风险。
比较1994年采用肌酸激酶同工酶MB(活性法)检测排除心肌梗死后从心脏急诊室出院回家的患者,与1996年采用快速肌酸激酶同工酶MB(质量法)检测后出院回家的患者在随访30天、6个月和24个月时心脏死亡和急性心肌梗死的合并发生率。
一家大型大学医院的心脏急诊室。
1994年和1996年,分别有230例和423例胸痛患者从心脏急诊室出院回家,其肌酸激酶同工酶MB检测结果正常,观察期平稳。
在心脏急诊室的中位留观时间显著缩短,从1994年的16.0小时降至1996年的9.0小时(p<0.0001)。1994年和1996年队列患者的平均事件发生率分别为:30天时0.9%(95%置信区间(CI)-0.3%至2.1%)对0.7%(95%CI-0.1%至1.5%);六个月时3.0%(95%CI0.8%至5.2%)对2.8%(95%CI1.2%至4.4%);24个月时7.0%(95%CI3.7%至10.3%)对5.7%(95%CI3.5%至7.9%)。Kaplan-Meier生存分析显示,随访30天、6个月和24个月时平均无事件生存率无差异。
采用快速灵敏的肌酸激酶同工酶MB(质量法)检测及系列采样的排除心肌梗死方案,可缩短胸痛患者在心脏急诊室的留观时间,且不影响安全性。